Market

SkyLabs to Launch IPO as Global Medical Data Powerhouse
Tech & Innovation SkyLabs to Launch IPO as Global Medical Data Powerhouse

Securing CE-MDR clearance has allowed SkyLabs to establish robust distribution networks in the United Kingdom and throughout mainland Europe's healthcare systems. This strategic milestone marks a significant step for the South Korean technology pioneer as it prepares for its transition to the

How Can Mankind Pharma Balance ESG Growth and Global Scaling?
Management & Regulatory How Can Mankind Pharma Balance ESG Growth and Global Scaling?

The company reported a consolidated revenue of ₹4,031 crore for the first quarter of fiscal year 2027, reflecting a significant 12.89% annual growth. This financial achievement underscores the robust performance of its domestic portfolio, which continues to outpace the general Indian pharmaceutical

What Drives the France Single-Use Bioprocessing Market?
Management & Regulatory What Drives the France Single-Use Bioprocessing Market?

Biopharmaceutical companies in France are utilizing disposable systems to remain competitive by shortening the downtime required between different product batches. This shift represents a fundamental realignment of industrial priorities, moving away from the rigid, permanent infrastructure of the

Citius Pharmaceuticals Advances LYMPHIR Sales and Pipeline
Research & Development Citius Pharmaceuticals Advances LYMPHIR Sales and Pipeline

A record 383 vials of LYMPHIR were ordered in July, establishing a new performance benchmark for the company’s expanded 29-member nationwide sales infrastructure. This milestone represents a significant pivot for Citius Pharmaceuticals as it transitions from a clinical-stage entity into a

WuXi Biologics Leads Industry in Sustainable Biopharma Innovation
Management & Regulatory WuXi Biologics Leads Industry in Sustainable Biopharma Innovation

Securing an MSCI AAA ESG rating and an EcoVadis Platinum Medal places WuXi Biologics in the top 1% of companies evaluated for environmental and social governance. This landmark achievement underscores the organization's role as a dominant force in the global healthcare market, particularly as it

Hims & Hers Navigates FTC Lawsuit and Strategic Pivot
Management & Regulatory Hims & Hers Navigates FTC Lawsuit and Strategic Pivot

Hims & Hers is currently navigating a complex period of transition as it trades its historical high-margin profile for a dominant position in the weight-loss sector. Operating at a volatile crossroads where rapid corporate expansion meets intense federal oversight, the leading telehealth platform

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later